Legal Perspective on Recent FDA Enforcements

Legal Perspective on Recent FDA Enforcements

Heather Bañuelos and Gillian Russell of King & Spalding will be presenting at the Life Science Advertising & Promotions Regulatory Affairs Conference this July. Preview their session “Update on Recent Enforcement of Regulations & Guidances Related to...
FDA Guidance’s Impact on Ad & Promo

FDA Guidance’s Impact on Ad & Promo

Glenn Byrd, an expert in strategic promotional regulatory affairs, is one of many professionals presenting at this year’s Life Science Advertising & Promotions Regulatory Affairs Conference. Preview some of the many topics featured at this year’s event below....

Bill Hagestad – Smiths Medical

2nd Annual Medical Device Cybersecurity Risk Mitigation Conference: Speaker Interview   Bill Hagestad Senior Principal Cyber Security Engineer, R&D Smiths Medical    Bill will be one of the distinguished speakers at the 2nd Annual Medical Device Cybersecurity...

Indivior Applies for Approval in Treating Opioid Abuse in U.S.

British pharmaceutical leader Indivior Plc announced this week its new drug application (NDA) to the U.S. Food and Drug Administration for its drug treating opioid use disorder (OUD). The drug, RBD-6000 acts as a monthly injectable opioid which in conjunction with...

David Festa – CooperSurgical

Semi-Annual Medical Device Supplier Quality Conference: Speaker Interview   David Festa Supplier Quality Manager CooperSurgical   David Festa is currently the Supplier Quality manager for CooperSurgical overseeing the implementation of the global supply base...